Bogart Wealth LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

by · The Cerbat Gem

Bogart Wealth LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 31,197.5% during the first quarter, Holdings Channel reports. The fund owned 12,519 shares of the medical equipment provider’s stock after purchasing an additional 12,479 shares during the period. Bogart Wealth LLC’s holdings in Intuitive Surgical were worth $6,200,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $25,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the 4th quarter worth $26,000. Chilton Capital Management LLC raised its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Finally, Global Financial Private Client LLC raised its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director directly owned 6,371 shares in the company, valued at $3,312,920. The trade was a 27.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 2.7%

Shares of NASDAQ ISRG opened at $512.06 on Monday. The stock has a market capitalization of $183.53 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 5.43 and a beta of 1.64. The stock’s fifty day simple moving average is $537.85 and its two-hundred day simple moving average is $536.67. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the firm earned $1.50 EPS. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on ISRG shares. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Thursday, June 5th. Piper Sandler reduced their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 23rd. Finally, Truist Financial reduced their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $592.59.

Read Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).